Literature DB >> 8512038

The leukemia inhibitory factor and its receptor.

D P Gearing1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512038     DOI: 10.1016/s0065-2776(08)60497-6

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  17 in total

1.  Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.

Authors:  I Shimon; X Yan; D W Ray; S Melmed
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

2.  Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia.

Authors:  L R Banner; P H Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

3.  Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants.

Authors:  D A Knight; A C D'Aprile; L J Spalding; R G Goldie; P J Thompson
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate.

Authors:  Flavie Sicard; Monika Ehrhart-Bornstein; Denis Corbeil; Simone Sperber; Alexander W Krug; Christian G Ziegler; Valeria Rettori; Samuel M McCann; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

5.  LIF is a new p53 negative regulator.

Authors:  Juan Liu; Haiyang Yu; Wenwei Hu
Journal:  J Nat Sci       Date:  2015

6.  LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.

Authors:  Dahu Chen; Yutong Sun; Yongkun Wei; Peijing Zhang; Abdol Hossein Rezaeian; Julie Teruya-Feldstein; Sumeet Gupta; Han Liang; Hui-Kuan Lin; Mien-Chie Hung; Li Ma
Journal:  Nat Med       Date:  2012-09-23       Impact factor: 53.440

7.  A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.

Authors:  Paul G Tiffen; Nader Omidvar; Nuria Marquez-Almuina; Dawn Croston; Christine J Watson; Richard W E Clarkson
Journal:  Mol Endocrinol       Date:  2008-10-16

8.  Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.

Authors:  T Bellido; N Stahl; T J Farruggella; V Borba; G D Yancopoulos; S C Manolagas
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

Review 9.  Mannose 6-phosphate receptor targeting and its applications in human diseases.

Authors:  M Gary-Bobo; P Nirdé; A Jeanjean; A Morère; M Garcia
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines.

Authors:  Junya Kanda; Tatsuki Uchiyama; Naohisa Tomosugi; Masato Higuchi; Takashi Uchiyama; Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2009-11-14       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.